Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, today reported financial results for the first quarter ended Marc...
Read more
El equipo de la UCLM ha demostrado que la activación farmacológica del S1R con el compuesto PRE-084 es capaz de restaurar la plasticidad sináptica, -es decir, la capacidad del cerebro para adaptars...
Read more
Researchers of the University of Barcelona led a multidisciplinary team that designed, synthetized and pharmacologically validated these molecules that modulate a therapeutic target which has been lit...
Read more
La relación entre obesidad y demencia pone de relieve una idea fundamental: al actuar sobre ciertos factores de riesgo modificables, se puede no solo mejorar la salud general, sino también contribui...
Read more
The new therapy, made of nanofibers and trehalose, a sugar that naturally occurs in plants, traps and neutralizes toxic proteins to stop disease progression. Now trapped, the toxic proteins can no lon...
Read more
Algunos tipos de demencia son considerados potencialmente reversibles porque son consecuencia de trastornos que se pueden curar, al menos parcialmente. Por eso, es importante no asumir que una persona...
Read more
International research with Catalan participation reveals that errors in non-coding genes, key in RNA processing, cause neurodevelopmental disorders that have so far gone undiagnosed.
Read more
A new study confirms that children of people with schizophrenia or bipolar disorder have a higher risk of developing psychopathology compared to children whose parents do not have these conditions. Th...
Read more
A new review led by researchers at CNAG, based at the Barcelona Science Park, analyzes the current opportunities and challenges of mass spectrometry-based proteomics in the study of genetic muscle dis...
Read more
ApTOLL completó un estudio clínico de Fase 1b/2 para el ictus isquémico agudo con resultados positivos. Merck asumirá el desarrollo clínico y la comercialización del fármaco.
Read more
The study reveals molecular mechanisms in the rare disease known as adult-onset neuronal ceroid lipofuscinosis and opens new avenues for therapy development.
Read more
El Servicio de Neurología del Hospital público Universitario 12 de Octubre de la Comunidad de Madrid ha incorporado un nuevo equipo de monitorización Video-Electroencefalográfica que analiza el co...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
